Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statin-associated neuromyotoxicity.

Steven K Baker1, Mark A Tarnopolsky

  • 1Department of Pediatrics, McMaster University Medical Center, Hamilton, Ontario, Canada.

Timely Topics in Medicine. Cardiovascular Diseases
|October 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of baclofen and lorazepam on interhemispheric inhibition in humans.

Experimental physiology·2026
Same author

Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Muscle mitochondrial changes in antisynthetase syndrome and other idiopathic inflammatory myopathies.

Journal of neuropathology and experimental neurology·2025
Same author

Impact of high-intensity interval training on cardiometabolic health in patients with diabesity: a systematic review and meta-analysis of randomized controlled trials.

Diabetology & metabolic syndrome·2025
Same author

A Multi-Ingredient Supplement Improves Body Re-Composition, Ovarian Aging Markers, and Reproductive Success in Young and Middle-Aged Female Mice.

Biomolecules·2025
Same author

Multi-ingredient supplementation for combating sarcopenia and polymorbidity.

Current opinion in clinical nutrition and metabolic care·2025
Same journal

2nd international conference on hypertension, lipids, diabetes and stroke prevention.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Current challenges and directions in antithrombotic therapy.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Myocardial infarction.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Web-based medical symposia.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Coronary disease.

Timely topics in medicine. Cardiovascular diseases·2008
See all related articles

Statins, used to treat cardiovascular disease, can cause muscle and nerve toxicity. While muscle issues are usually reversible, nerve damage may be permanent, with disrupted mevalonate metabolism a potential cause.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Neurology

Background:

  • Cardiovascular disease is a leading cause of death, and statins effectively reduce atherosclerotic disease burden.
  • Statin use is associated with potential muscle (myopathy) and nerve (neuropathy) toxicities, leading to treatment discontinuation.
  • Understanding these adverse effects is crucial for patient management and adherence to cardiovascular therapies.

Purpose of the Study:

  • To review the pathophysiology of statin-induced neuromyotoxicity.
  • To discuss the role of disrupted mevalonate metabolism in statin-related muscle and nerve damage.
  • To explore potential therapeutic targets based on understanding isoprenoid biosynthesis defects.

Main Methods:

  • Literature review of studies on statin toxicity, myopathy, and neuropathy.

Related Experiment Videos

  • Analysis of biochemical pathways, particularly mevalonate metabolism and isoprenoid biosynthesis.
  • Discussion of clinical manifestations and reversibility of statin-induced side effects.

    • Main Results:

    • Statin myopathy, characterized by muscle pain and elevated creatine kinase (CK), is generally reversible upon drug cessation.
    • Sensorimotor neuropathy associated with statins may be less reversible, especially when large fiber function is affected.
    • Disrupted mevalonate metabolism impacts crucial isoprenoid intermediates, potentially causing cellular dysfunction and contributing to neuromyotoxicity.

    Conclusions:

    • Statin-induced neuromyotoxicity is a significant concern, impacting patient adherence and outcomes.
    • Defects in isoprenoid biosynthesis due to statin use offer a plausible explanation for cellular damage.
    • Further research into the cellular consequences of deranged isoprenoid metabolism is needed to fully elucidate the pathophysiology of statin neuromyotoxicity.